(3.236.214.19) 您好!臺灣時間:2021/05/10 07:29
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

: 
twitterline
研究生:許瑞玲
研究生(外文):Jui-Ling Hsu
論文名稱:1.利用短暫性殖入系統探討carbonicanhydrase與肝癌的關係2.silibinin對GSTisoforms表現之影響
論文名稱(外文):1.Study of the relationships between carbonic anhydrase and liver cancerous cells, the use of a transient expression system. 2.Effect of silibinin on the expression of GST isoforms
指導教授:周芬碧周芬碧引用關係
指導教授(外文):Fen-Pi Chou
學位類別:碩士
校院名稱:中山醫學院
系所名稱:生物化學研究所
學門:生命科學學門
學類:生物化學學類
論文種類:學術論文
論文出版年:2001
畢業學年度:89
語文別:中文
論文頁數:132
中文關鍵詞:carbonic anhydrase肝癌GST isoformssilibinin
外文關鍵詞:carbonic anhydraseliver cancerous cellsGST isoformssilibinin
相關次數:
  • 被引用被引用:0
  • 點閱點閱:107
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:13
  • 收藏至我的研究室書目清單書目收藏:1
1.CA是一種含鋅的金屬酵素,其分子量約為30kDa左右,廣泛分佈於動植物中,是屬於六大酉每裡面的Lyase。在二氧化碳的輸送或分泌過程扮演重要的角色。在之前的研究,發現接種肉瘤細胞Sarcoma 180的老鼠,肝臟組織之細胞質carbonic anhydrase III之表現,在六天後逐漸減少。此外也有報告指出在直腸大腸癌的病人,他們的CA I,II的表現是減少的。是什麼原因導致此現象並不清楚?所以本實驗乃使用短暫性殖入系統以探討carbonic anhydrase 與肝癌的關係,期望能找出一個解答。
實驗利用RT-PCR放大CA的基因序列,再接至GFP載體以得到CA的cloning,之後短暫性殖入肝癌細胞( Hep 3B )。結果發現CA的曲線經校正後有下降的趨勢;且在螢光顯微鏡下,殖入GFP-HCA II的細胞形狀與殖入GFP (控制組)的細胞形狀有些不同。隨時間增加,殖入GFP-HCA II細胞形狀呈現圓形的增多,且綠色螢光亮度增強,此圓亮的細胞最後會死亡。作TUNEL實驗,發現轉殖GFP-HCA II細胞,呈現螢光反應,表示細胞可能有apoptosis的現象。
結果顯示過度表現CA II可能對細胞造成傷害,必須作更多實驗來確認細胞的死亡是apoptosis或necrosis。
2.Glutathione S-transferase(GST)體內的解毒酵素在化學預防中扮演了重要的角色。由於當某些癌症形成時,GST pi form有明顯的大量表現,而治療癌症時GST alpha form又與藥物產生抗藥性有關,所以使用天然藥物能降低(抑制)GST pi及GST alpha form的表現,對於治療癌症是有益的,可使得抗癌藥的效果增強而達到治療癌症的目的。
在本實驗中是利用肝癌細胞(Hep G2、3B cell),以Western blotting及RT-PCR的方法探討silibinin,EGCG,PCA,geniposide等天然藥物對於Glutathione-S Transferase 基因表現的影響,結果G2及3B細胞以EGCG和silibinin處理後,發現GST alpha mRNA的量都是下降的,且GST mu mRNA的量是上升的(3B細胞)。另外以silibinin處理,GST alpha mRNA的量呈現dose-dependent,time-dependent。
所以初步認為silibinin在預防及治療癌症上是不錯的天然藥物。進一步還須合併抗癌藥,證明silibinin的確可以幫助癌症的治療。

Carbonic anhydrases are zinc-containing metalloenzymes with molecular weights about 30 kDa that are widely distributed in animals and plants. CAs belong to lyases. CAs play an important role in transportation or secretion of carbon dioxide. In previously study, we found that mouse inoculated with sarcoma 180 cells showed a gradual decrease in the expression of CA III in the liver 6 days after the inoculation. Other reports also demonstrated that the expressions of CA I and II were reduced in colorectal tumors. In order to understand the role of CAs in cancer development, a transient expression system was used to explore the effect of over-expressed CA II on liver cancerous cells.
1.Hepatoblastoma cells (Hep 3B) were transfected with cDNA of CA II that was amplified by RT-PCR and cloned into pGFP vector. The results, after normalized with transfection efficiency, showed that the number of cells transfected with CA II gradually decreased as the culture time increased. Furthermore, the cells transfected with CA II were morphologically different from that of control cells. The number of cells that were round in shape and bright in green fluorescence increased along with the increasing culture time. These cells were not viable. The results of TUNEL assay found that the cells transfected with GFP-HCA II presented fluorescence indicating that these cells may be apoptotic cells.
These results indicated that over-expression of CA II might be toxic to cells. Further study will be needed to clarify the cause of their death, apoptosis or necrosis.
2.Glutathione S —transferases are detoxifying enzymes and play important roles in chemoprevention. However, the expression of GST pi subunits were linked to the development of several cancers, and the increases in GST alpha subunits were related to the drug-resistance of cancers. Therefore, a compound that could decrease the expression of GST pi or alpha would be beneficial in treating cancers, such as enhancing the efficiency of anticancer drugs by decreasing drug-resistance.
In this study, we tested the effect of several natural compounds, including silibinin, EGCG, PCA and geniposide on the gene expressions of GST subunits. Using Western blotting and RT-PCR analyses, we found that the treatment of EGCG and silibinin on hepatoblastoma cells (Hep G2 and 3B) reduced the mRNA levels of GST alpha in both cell lines, and increased the transcripts of GST mu in 3B cells. The reduction of GST alpha mRNA level by silibinin was dose- and time-dependent.
These results suggested that silibinin would be advantageous in cancer treatment. Further study using combination of silibinin and anticancer drug will be needed to demonstrate the actual effect of the compound in helping cancer treatment.

中文摘要……………………………………………………………..1
英文摘要……………………………………………………………..2
背景介紹……………………………………………………………..3
動機………………………………………………………………….12
實驗方法…………………………………………………………….13
結果………………………………………………………………….30
討論………………………………………………………………….35
圖表與圖表說明…………………………………………………….39
參考文獻…………………………………………………………….64
第二部份:silibinin對GST isoforms 表現之影響
中文摘要…………………………………………………………….69
英文摘要…………………………………………………………….70
背景介紹…………………………………………………………….71
動機………………………………………………………………….87
實驗方法…………………………………………………………….88
結果………………………………………………………………….99
討論…………………………………………………………………104
圖表與圖表說明……………………………………………………108
參考文獻……………………………………………………………124

1 Iverson TM. Alber BE. Kisker C. Ferry JG. Rees DC. A closer look at the active site of gamma-class carbonic anhydrases: high-resolution crystallographic studies of the carbonic anhydrase from Methanosarcina thermophila. Biochemistry. 39(31):9222-31, 2000.
2 McCall KA. Huang C. Fierke CA. Function and mechanism of zinc metalloenzymes. [Review] [115 refs] Journal of Nutrition. 130(5S Suppl):1437S-46S, 2000.
3 Iverson TM. Alber BE. Kisker C. Ferry JG. Rees DC. A closer look at the active site of gamma-class carbonic anhydrases: high-resolution crystallographic studies of the carbonic anhydrase from Methanosarcina thermophila. Biochemistry. 39(31):9222-31, 2000.
4 Sly WS. Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. [Review] [177 refs] Annual Review of Biochemistry. 64:375-401, 1995.
5 Parkkila AK. Parkkila S. Serlo W. Reunanen M. Vierjoki T. Rajaniemi H. A competitive dual-label time-resolved immunofluorometric assay for simultaneous detection of carbonic anhydrase I and II in cerebrospinal fluid. Clinica Chimica Acta. 230(1):81-9, 1994.
6 Parkkila S. Parkkila AK. Juvonen T. Rajaniemi H. Distribution of the carbonic anhydrase isoenzymes I, II, and VI in the human alimentary tract. Gut. 35(5):646-50,
7 Juvonen T. Parkkila S. Parkkila AK. Niemela O. Lajunen LH. Kairaluoma MI. Peramaki P. Rajaniemi H. High-activity carbonic anhydrase isoenzyme (CA II) in human gallbladder epithelium. Journal of Histochemistry & Cytochemistry. 42(10):1393-7, 1994.
8 Henry RP. Multiple roles of carbonic anhydrase in cellular transport and metabolism. [Review] [108 refs] Annual Review of Physiology. 58:523-38, 1996.
9 Cabiscol E. Levine RL. Carbonic anhydrase III. Oxidative modification in vivo and loss of phosphatase activity during aging. Journal of Biological Chemistry. 270(24):14742-7, 1995.
10 Williams RJ. Energised (entatic) states of groups and of secondary structures in proteins and metalloproteins. [Review] [76 refs] European Journal of Biochemistry. 234(2):363-81, 1995.
11 Saarnio J. Parkkila S. Parkkila AK. Waheed A. Karttunen T. Sly WS. Cell-specific expression of mitochondrial carbonic anhydrase in the human and rat gastrointestinal tract. Journal of Histochemistry & Cytochemistry. 47(4):517-24, 1999.
12 Kivela J. Parkkila S. Parkkila AK. Leinonen J. Rajaniemi H. Salivary carbonic anhydrase isoenzyme VI. [Review] [64 refs] Journal of Physiology. 520 Pt 2:315-20, 1999.
13 Kivela J. Parkkila S. Parkkila AK. Rajaniemi H. A low concentration of carbonic anhydrase isoenzyme VI in whole saliva is associated with caries prevalence. Caries Research. 33(3):178-84, 1999.
14 Kivela J. Parkkila S. Waheed A. Parkkila AK. Sly WS. Rajaniemi H. Secretory carbonic anhydrase isoenzyme (CA VI) in human serum. Clinical Chemistry. 43(12):2318-22, 1997.
15 Parkkila S. Parkkila AK. Lehtola J. Reinila A. Sodervik HJ. Rannisto M. Rajaniemi H. Salivary carbonic anhydrase protects gastroesophageal mucosa from acid injury. Digestive Diseases & Sciences. 42(5):1013-9, 1997.
16 Kivela J. Parkkila S. Metteri J. Parkkila AK. Toivanen A. Rajaniemi H. Salivary carbonic anhydrase VI concentration and its relation to basic characteristics of saliva in young men. Acta Physiologica Scandinavica. 161(2):221-5, 1997.
17 Parkkila S. Parkkila AK. Kaunisto K. Waheed A. Sly WS. Rajaniemi H. Location of a membrane-bound carbonic anhydrase isoenzyme (CA IV) in the human male reproductive tract. Journal of Histochemistry & Cytochemistry. 41(5):751-7, 1993.
18 Fleming RE. Parkkila S. Parkkila AK. Rajaniemi H. Waheed A. Sly WS. Carbonic anhydrase IV expression in rat and human gastrointestinal tract regional, cellular, and subcellular localization. Journal of Clinical Investigation. 96(6):2907-13, 1995.
19 Pastorekova S. Parkkila S. Parkkila AK. Opavsky R. Zelnik V. Saarnio J. Pastorek J. Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology. 112(2):398-408, 1997.
20 Saarnio J. Parkkila S. Parkkila AK. Haukipuro K. Pastorekova S. Pastorek J. Kairaluoma MI. Karttunen TJ. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. [see comments]. American Journal of Pathology. 153(1):279-85, 1998.
21 Liao SY. Brewer C. Zavada J. Pastorek J. Pastorekova S. Manetta A. Berman ML. DiSaia PJ. Stanbridge EJ. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. American Journal of Pathology. 145(3):598-609, 1994.
22 McKiernan JM. Buttyan R. Bander NH. Stifelman MD. Katz AE. Chen MW. Olsson CA. Sawczuk IS. Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. Cancer Research. 57(12):2362-5, 1997.
23 Tureci O. Sahin U. Vollmar E. Siemer S. Gottert E. Seitz G. Parkkila AK. Shah GN. Grubb JH. Pfreundschuh M. Sly WS. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proceedings of the National Academy of Sciences of the United States of America. 95(13):7608-13, 1998.
24 Karhumaa P. Parkkila S. Tureci O. Waheed A. Grubb JH. Shah G. Parkkila A. Kaunisto K. Tapanainen J. Sly WS. Rajaniemi H. Identification of carbonic anhydrase XII as the membrane isozyme expressed in the normal human endometrial epithelium. Molecular Human Reproduction. 6(1):68-74, 2000.
25 Türeci Ö. Sahin U. Vollmar E. Siemer S. Göttert E. Seitz G. Parkkila A. Shah GN. Grubb J. H. Pfrundschuh M. Sly WS. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proceedings of the National Academy of Sciences of the United States of America.Proc. 95(3):7608-7613,1998.
26 Sly WS. Grubb JH. Shah G. Tureci O. Rajaniemi H. Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. American Journal of Pathology. 156(2):577-84, 2000.
27 Saarnio JM. Parkkila S. Parkkila AK. Haukipuro K. Pastoreková S. Pastorek J. Kairaluoma MI. Karttunen TJ. Immunohistochemical Study of Colorectal Tumors for expression of a novel trans membrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. American Journal of Pathology. 153(4):279-285, 1998.
28 Mori K. Ogawa Y. Ebihara K. Tamura N. Tashiro K. Kuwahara T. Mukoyama M. Sugawara A. Ozaki S. Tanaka I. Nakao K. Isolation and characterization of CA XIV, a novel membrane-bound carbonic anhydrase from mouse kidney. Journal of Biological Chemistry. 274(22):15701-5, 1999.
29 Botre F. Gros G. Storey BT. Carbonic anhydrase: From Biochemistry and Genetics to Physiology and Molecular Genetics. New York: Plenum. 1991.
30 Christianson DW. Cox JD. Catalysis by metal-activated hydroxide in zinc and manganese metalloenzymes. [Review] [85 refs] Annual Review of Biochemistry. 68:33-57, 1999.
31 Tashian RE. The carbonic anhydrases: widening perspectives on their evolution, expression and function. [Review] [42 refs] Bioessays. 10(6):186-92, 1989.
32 Cameron JN. Excretion of CO2 in water-breathing animals: a short review. Marine of Biological Letter. 1:3-13, 1979
33 Liljas A. Hakansson K. Jonsson BH. Xue Y. Inhibition and catalysis of carbonic anhydrase. Recent crystallographic analyses. [Review] [69 refs] European Journal of Biochemistry. 219(1-2):1-10, 1994.
34 Gay CV. Role of microscopy in elucidating the mechanism and regulation of the osteoclast resorptive apparatus. [Review] [74 refs] Microscopy Research & Technique. 33(2):165-70, 1996.
35 Sundaram V. Rumbolo P. Grubb J. Strisciuglio P. Sly WS. Carbonic anhydrase II deficiency: diagnosis and carrier detection using differential enzyme inhibition and inactivation. American Journal of Human Genetics. 38(2):125-36, 1986.
36 Sundaram V. Rumbolo P. Grubb J. Strisciuglio P. Sly WS. Carbonic anhydrase II deficiency: diagnosis and carrier detection using differential enzyme inhibition and inactivation. American Journal of Human Genetics. 38(2):125-36, 1986.
37 Kiechle FL. Diagnostic molecular pathology in the twenty-first century. [Review] [84 refs] Clinics in Laboratory Medicine. 16(1):213-22, 1996.
38 盧秀琴. 接種肉瘤細胞(Sarcoma 180)老鼠各臟器之蛋白質及gelatinase活性變化分析. 私立中山醫學院生化研究所碩士論文, 135, 1999
39 Parkkila S. Rajaniemi H. Parkkila AK. Kivela J. Waheed A. Pastorekova S. Pastorek J. Sly WS. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proceedings of the National Academy of Sciences of the United States of America. 97(5):2220-4, 2000.
40 Parkkila S. Parkkila AK. Juvonen T. Lehto VP. Rajaniemi H. Immunohistochemical demonstration of the carbonic anhydrase isoenzymes I and II in pancreatic tumours. Histochemical Journal. 27(2):133-8, 1995.
41 Kairaluoma MI. Karttunen TJ. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. [see comments]. American Journal of Pathology. 153(1):279-85, 1998.
42 Kivela A. Parkkila S. Saarnio J. Karttunen TJ. Kivela J. Parkkila AK. Waheed A. Sly WS. Grubb JH. Shah G. Tureci O. Rajaniemi H. Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. American Journal of Pathology. 156(2):577-84, 2000.
43 Nogradi A. The role of carbonic anhydrases in tumors. [letter; comment]. American Journal of Pathology. 153(1):1-4, 1998.

QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
系統版面圖檔 系統版面圖檔